AstraZeneca Pharma, in an exchange filing, said it has received the CDSCO’s permission to import for sales and distribution of the solution for infusion 120 mg/2.4 ml and 500mg/10 ml for an additional indication.
AstraZeneca Pharma, in an exchange filing, said it has received the CDSCO’s permission to import for sales and distribution of the solution for infusion 120 mg/2.4 ml and 500mg/10 ml for an additional indication.